| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.53▼ | 4.55▼ | 4.59▼ | 4.43▲ | 4.19▲ |
| MA10 | 4.53▲ | 4.60▼ | 4.57▼ | 4.33▲ | 4.09▲ |
| MA20 | 4.54▼ | 4.57▼ | 4.51▲ | 4.16▲ | 4.22▲ |
| MA50 | 4.61▼ | 4.49▲ | 4.47▲ | 3.99▲ | N/A |
| MA100 | 4.56▼ | 4.44▲ | 4.23▲ | 4.22▲ | N/A |
| MA200 | 4.49▲ | 4.22▲ | 4.10▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.016▼ | -0.003▼ | 0.045▲ | 1.202▲ |
| RSI | 40.736▼ | 47.554▼ | 52.876▲ | 64.219▲ | 32.112▼ |
| STOCH | 51.389 | 23.801 | 52.118 | 68.734 | 72.163 |
| WILL %R | -50.000 | -80.952▼ | -61.818 | -19.780▲ | -9.890▲ |
| CCI | 7.752 | -85.862 | -23.658 | 89.100 | 121.793▲ |
| ▼ GAP | $BIOA Open Gap Down %2 | Set Alert |
|
Friday, June 13, 2025 12:45 AM
BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that the interim safety review of the clinical Phase 2a study EXIST showed exidavnemab to be safe and well-tolerated, whereby the second ...
|
|
Thursday, June 12, 2025 11:37 PM
BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that the interim safety review of the clinical Phase 2a study EXIST ...
|
|
Thursday, May 29, 2025 08:18 PM
BioAge Labs, Inc. (NASDAQ:BIOA), a clinical-stage biotech innovator, announced today the completion of IND-enabling studies for its groundbreaking oral NLRP3 inhibitor, BGE-102, targeting obesity. The ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 4.37 | 4.70 | 4.36 | 4.52 | 261,300 |
| 12/06/25 | 4.43 | 4.56 | 4.425 | 4.49 | 147,600 |
| 11/06/25 | 4.40 | 4.48 | 4.35 | 4.44 | 162,900 |
| 10/06/25 | 4.34 | 4.485 | 4.34 | 4.39 | 150,122 |
| 09/06/25 | 4.48 | 4.525 | 4.26 | 4.30 | 157,260 |
| 06/06/25 | 4.55 | 4.69 | 4.45 | 4.45 | 286,100 |
| 05/06/25 | 4.32 | 4.589 | 4.275 | 4.44 | 551,990 |
| 04/06/25 | 4.06 | 4.38 | 3.93 | 4.27 | 1,705,024 |
| 03/06/25 | 4.01 | 4.08 | 3.95 | 3.99 | 1,000,785 |
| 02/06/25 | 3.98 | 4.11 | 3.95 | 4.05 | 194,205 |
|
|
||||
|
|
||||
|
|